Assessing equivalence and noninferiority.

نویسندگان

  • Jonathan R Treadwell
  • Stacey Uhl
  • Kelley Tipton
  • Tatyana Shamliyan
  • Meera Viswanathan
  • Nancy D Berkman
  • Xin Sun
  • Craig I Coleman
  • Adam G Elshaug
  • Sonal Singh
  • Shi-Yi Wang
  • Rema Ramakrishnan
چکیده

OBJECTIVE For systematic reviews, no guidance exists for what review methods support valid conclusions of equivalence (EQ) and noninferiority (NI). To provide such guidance, we convened a workgroup of 13 experienced systematic reviewers from seven evidence-based practice centers (EPCs) and the Agency for Healthcare Research and Quality (AHRQ). STUDY DESIGN AND SETTING The Lead EPC first performed two methods projects intended to assist the workgroup in clarifying the context, prioritizing the issues, targeting the scope, and summarizing the state of the art. RESULTS Based on expert opinion, we devised guidance in four areas: 1) Unique risk of bias issues for trials self-identifying as EQ-NI trials; 2) Setting the reviewer's minimum important difference; 3) Analytic foundations for concluding EQ or NI; and 4) Language considerations when concluding EQ or NI. CONCLUSION This article summarizes the main recommendations, and the full guidance chapter appears on the AHRQ Web site.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

More powerful exact noninferiority and equivalence tests based on binary matched pairs

Assessing the therapeutic noninferiority or equivalence of one medical treatment compared to another is often based on the difference of response rates from a matched binary pairs design. This paper develops new exact unconditional tests for noninferiority and equivalence that are more powerful than available alternatives. There are three new elements presented in this paper. First we introduce...

متن کامل

Quality of reporting of noninferiority and equivalence randomized trials.

CONTEXT Noninferiority and equivalence trials aim to show that the experimental treatment is not clinically worse than (noninferior) or clinically similar to (equivalent) a control active treatment. These study objectives imply particular planning and analysis. OBJECTIVE To assess the methodologic quality of reports of randomized controlled trials of noninferiority and equivalence. DESIGN W...

متن کامل

Equivalence and noninferiority testing in regression models and repeated-measures designs.

Equivalence and noninferiority designs are useful when the superiority of one intervention over another is neither expected nor required. Equivalence trials test whether a difference between groups falls within a prespecified equivalence region, whereas noninferiority trials test whether a preferred intervention is either better or at least not worse than the comparator, with worse being define...

متن کامل

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

The CONSORT (Consolidated Standards of Reporting Trials) Statement, including a checklist and a flow diagram, was developed to help authors improve their reporting of randomized controlled trials. Its primary focus was on individually randomized trials with 2 parallel groups that assess the possible superiority of one treatment compared with another but is now being extended to other trial desi...

متن کامل

SPECIAL COMMUNICATION Reporting of Noninferiority and Equivalence Randomized Trials An Extension of the CONSORT Statement

THE CONSOLIDATED STANdards of Reporting Trials (CONSORT) statement was developed to alleviate the problem of inadequate reporting of randomized controlled trials (RCTs), which has been associated with biased treatment effects. The statement comprises evidence-based recommendations for reporting RCTs, including a flowchart of participants through the trial. CONSORT’s primary focus is on parallel...

متن کامل

Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

The CONSORT (Consolidated Standards of Reporting Trials) Statement, which includes a checklist and a flow diagram, is a guideline developed to help authors improve the reporting of the findings from randomized controlled trials. It was updated most recently in 2010. Its primary focus is on individually randomized trials with 2 parallel groups that assess the possible superiority of one treatmen...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Journal of clinical epidemiology

دوره 65 11  شماره 

صفحات  -

تاریخ انتشار 2012